Stockholders' Deficiency (Details 4) (USD $)	3 Months Ended
	Mar. 31, 2013
Number of warrants, outstanding
Outstanding, beginning of period (in shares)	592,846
Granted	13,580,023
Exercised	(8,125,750)
Forfeited
Outstanding, end of period (in shares)	6,047,119
Exercisable, March 31, 2013	5,767,119
Warrants, weighted average exercise price
Outstanding, beginning of period (in dollars per share)	$ 3.01
Granted	$ 0.28
Exercised	$ 0.25
Forfeited
Outstanding, end of period (in dollars per share)	$ 0.58
Exercisable, March 31, 2013	$ 0.46
Weighted Average Remaining Life In Years
Weighted Average Remaining Life (in years) Outstanding	4 years 8 months 12 days
Weighted Average Remaining Life (in years) Exercisable	4 years 9 months 18 days
Aggregate Intrinsic Value
Aggregate Intrinsic Value Outstanding	$ 4,618,507
Aggregate Intrinsic Value Exercisable	$ 4,618,507